Scandion Oncology Management
Management criteria checks 0/4
Scandion Oncology's CEO is Francois Martelet, appointed in Jan 2023, has a tenure of 1.5 years. directly owns 0.027% of the company’s shares, worth SEK4.88K. The average tenure of the management team and the board of directors is 1.5 years and 2.8 years respectively.
Key information
Francois Martelet
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.5yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.5yrs |
| Board average tenure | 2.8yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Francois Martelet (64 yo)
1.5yrs
Tenure
Dr. Francois Regis Martelet, M.D. is a Non-executive Director of Novigenix SA since June 2019. He had been the Chief Executive Officer of Vivesto AB (formerly known as Oasmia Pharmaceutical AB (publ)) sinc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer | 1.5yrs | no data | 3.32% DKK 589.3k | |
| Chief Executive Officer | 1.5yrs | no data | 0.027% DKK 4.9k | |
| Chief Financial Officer | 2.9yrs | no data | 0.033% DKK 5.8k | |
| General Counsel | no data | no data | no data | |
| Head of External Communication | 2.5yrs | no data | no data | |
| Chief Medical Officer | 1.5yrs | no data | no data |
1.5yrs
Average Tenure
Experienced Management: SCOL BTU's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | 3.3yrs | no data | no data | |
| Independent Deputy Chairman of the Board | 2.3yrs | no data | no data | |
| Member of Clinical Advisory Board | 2.8yrs | no data | no data | |
| Member of Clinical Advisory Board | 2.8yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.3yrs | no data | no data | |
| Member of Clinical Advisory Board | 2.8yrs | no data | no data | |
| Independent Chairman of the Board | 3.2yrs | no data | 0.015% DKK 2.7k | |
| Independent Director | less than a year | no data | no data |
2.8yrs
Average Tenure
63yo
Average Age
Experienced Board: SCOL BTU's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.